COVID-19 with spontaneous pneumothorax, pneumomediastinum, and subcutaneous emphysema in the intensive care unit: Two case reports

J Infect Public Health. 2021 Mar;14(3):290-292. doi: 10.1016/j.jiph.2020.12.019. Epub 2020 Dec 29.

Abstract

Real-Time-reverse-transcription-Polymerase-Chain-Reaction from nasopharyngeal swabs and chest computed tomography (CT) depicting typically bilateral ground-glass opacities with a peripheral and/or posterior distribution are mandatory in the diagnosis of COVID-19. COVID-19 pneumonia may present though with atypical features such as pleural and pericardial effusions, lymphadenopathy, cavitations, and CT halo sign. In these two case-reports, COVID-19 presented as pneumothorax, pneumomediastinum and subcutaneous emphysema in critically ill patients. These disorders may require treatment or can be even self-limiting. Clinicians should be aware of their potential effects on the cardiorespiratory status of critically ill COVID-19 patients. Finally, pneumothorax can be promptly diagnosed by means of lung ultrasound. Although operator dependent, lung ultrasound is a useful bedside diagnostic tool that could alleviate the risk of cross-infection related to COVID-19 patient transport.

Keywords: COVID-19; Chest computed tomography; Lung ultrasound; Pneumomediastinum; Pneumothorax; Subcutaneous emphysema.

Publication types

  • Case Reports

MeSH terms

  • COVID-19 / complications*
  • Humans
  • Intensive Care Units
  • Male
  • Mediastinal Emphysema* / diagnostic imaging
  • Mediastinal Emphysema* / virology
  • Middle Aged
  • Pneumothorax* / diagnostic imaging
  • Pneumothorax* / virology
  • Subcutaneous Emphysema* / diagnostic imaging
  • Subcutaneous Emphysema* / virology